TNFRSF1A and neoplasm: However, also the broadly proinflammatory TNFRs fibroblast growth factor inducible-14 (Fn14) and TNFR1 as well as the cytotoxic TNF-related apoptosis-inducing ligand (TRAIL) death receptors and CD95 attract considerable interest as targets in tumor therapy (6–9).